1) re-resection
再手术切除
1.
To evaluate the effect of re-resection for intrahepatic recurrent cancer and extrahepatic metastases of primary hepatocellular carcinoma.
[目的]探讨原发性肝癌术后肝内复发与肝外转移再手术切除的疗效。
2) Re resection
再切除术
4) surgery
[英]['sɜ:dʒəri] [美]['sɝdʒərɪ]
手术切除
1.
Objective To evaluate the tolerance and the short-term outcome of preoperative chemotherapy plus surgical resection for patients with locally advanced esophageal squamous carcinoma and observe the effects of preoperative chemotherapy on tumor resection rate,incidence of complications after surgery,and perioperative mortality.
2%,病理完全缓解率32%,手术切除率100%,术后肺部感染、吻合口瘘、手术死亡率分别是34。
5) Resection
[英][ri'sekʃən] [美][rɪ'sɛkʃən]
手术切除
1.
Effects of specimens shrinkage by surgical resection and fixation on esophageal and gastric cardia cancers
食管癌和贲门癌手术切除标本离体前后及固定后的收缩变化
2.
1% of primary resection.
结论转移性肝癌的早期诊断是提高生存率的关键,联合应用多种影像学方法是提高诊断率的有效手段,手术切除及选择性肝动脉栓塞化疗是治疗的较好选择。
3.
Aim: To compare the efficiency of transcatheter arterial chemoembolization(TACE) and TACE combining subsequent resection in advanced hepatocellular carcinoma.
目的 :探讨不能手术切除的中晚期肝细胞肝癌 (HCC)经导管肝动脉栓塞化疗 (TACE)后的再治疗方法。
补充资料：巴-斯氏扁桃体挤切除器